Literature DB >> 11500619

Recurrent peritoneal mesothelioma with long-delayed recurrence.

A Tandar1, G Abraham, J Gurka, M Wendel, L Stolbach.   

Abstract

Peritoneal mesothelioma is a rare malignancy with a poor prognosis. Etiology is unclear and presentation of this disease is often atypical. There are very few cases of long-term survival in patients with peritoneal mesothelioma. We report the case of a patient with peritoneal mesothelioma of 19 years' duration. To the best of our knowledge, there have been no reports of recurrent peritoneal mesothelioma with such long-delayed recurrence and survival. Recurrent peritoneal mesothelioma in the current patient was confirmed by comparing the biopsies of omentum taken in 1979 with that taken in 1997. An extensive literature search was undertaken to look for previous reports of recurrent peritoneal mesothelioma. Aggressive and intensive chemotherapy appeared to provide a longer survival time. Our patient had paraneoplastic manifestations that included paraneoplastic hepatopathy and a wasting syndrome. Peritoneal mesothelioma is a rare malignancy with one to two cases per million in the United States. It is known to exhibit unusual paraneoplastic manifestations, including paraneoplastic hepatopathy. Treatment is often unsuccessful, with a median survival time of approximately 18 months from diagnosis. A better understanding and aggressive management of this disease appear to help prolong survival.

Entities:  

Mesh:

Year:  2001        PMID: 11500619     DOI: 10.1097/00004836-200109000-00018

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  9 in total

1.  Malignant peritoneal mesothelioma in a pediatric patient mimicking inflammatory bowel disease.

Authors:  Cynthia Oberto; Kathleen B Schwarz; Elias Zambidis; Andrew B Campbell; Charles Paidas; Kenneth Lindyberg; Maria Oliva-Hemker
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

2.  Unusual presentation of a late-onset recurrence of malignant peritoneal mesothelioma.

Authors:  Marije Wijnberge; Lidewine Daniels; Vincent Cliteur; Jasper Winkelhagen
Journal:  BMJ Case Rep       Date:  2017-03-06

Review 3.  Splenic localization of the peritoneal mesothelioma: case report and literature revue.

Authors:  Dario D'Abbicco; Angelica Conversano; Barbara Rita Epifania; Rocco Indellicato; Antonio Margari
Journal:  Updates Surg       Date:  2011-06-10

Review 4.  Surgical biology for the clinician: peritoneal mesothelioma: current understanding and management.

Authors:  Terence C Chua; Tristan D Yan; David L Morris
Journal:  Can J Surg       Date:  2009-02       Impact factor: 2.089

Review 5.  Peritoneal mesothelioma: a review.

Authors:  Alessio Bridda; Ilaria Padoan; Roberto Mencarelli; Mauro Frego
Journal:  MedGenMed       Date:  2007-05-10

6.  Replenishable drug depot to combat post-resection cancer recurrence.

Authors:  Yevgeny Brudno; Matthew J Pezone; Tracy K Snyder; Oktay Uzun; Christopher T Moody; Michael Aizenberg; David J Mooney
Journal:  Biomaterials       Date:  2018-05-06       Impact factor: 12.479

7.  Localized multiple malignant epithelioid peritoneal mesotheliomas arising from the hepatoduodenal ligament and diaphragm: a case report.

Authors:  Takashi Miyata; Yuta Fujiwara; Koji Nishijima; Fumio Futagami; Takashi Nakamura; Hiroyuki Takamura
Journal:  J Med Case Rep       Date:  2019-03-18

8.  Pleural mesothelioma presenting as periumbilical metastasis: the first clinical documentation.

Authors:  R F Falkenstern-Ge; M Kimmich; S Bode-Erdmann; G Friedel; G Ott; M Kohlhäufl
Journal:  Case Rep Oncol Med       Date:  2013-04-18

9.  Primary diffuse malignant peritoneal mesothelioma in a striped skunk (Mephitis mephitis).

Authors:  Su-Min Kim; Yeonsu Oh; Suk-Hun Oh; Jeong-Hee Han
Journal:  J Vet Med Sci       Date:  2015-11-14       Impact factor: 1.267

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.